C3 Polymorphisms and Allograft Outcome in Renal Transplantation

  • Varagunam M
  • Yaqoob M
  • Döhler B
  • et al.
65Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND: Complement activation plays a role in the development of chronic allograft nephropathy, a common cause of late allograft loss. The role of two complement component 3 (C3) allotypes, called C3F (fast) and C3S (slow) on the basis of their electrophoretic motility, in the long-term outcome of renal allografts remains controversial.METHODS: We selected a random sample of 1147 donor and recipient pairs from the Collaborative Transplant Study DNA bank, and their DNA specimens were genotyped for the C3F and C3S alleles. The genotyping results were analyzed according to allograft outcome. Transplants were divided into four groups, according to the recipient and donor genotypes: SS recipient and FS or FF donor (the standard for comparison, since this combination has been reported to have the best outcome), SS recipient and donor, FS or FF recipient and SS donor, and FS or FF recipient and donor.RESULTS: Baseline characteristics of the four transplant groups were similar. The hazard ratios for allograft survival in the SS recipient and FS or FF donor group as compared with the other three groups (SS recipient and donor, FS or FF recipient and SS donor, and FS or FF recipient and donor) were not significant: 0.90 (95% confidence interval [CI], 0.7 to 1.14; P=0.33), 0.87 (95% CI, 0.65 to 1.16; P=0.33), and 0.89 (95% CI, 0.65 to 1.23; P=0.48), respectively. The four groups had similar patient-survival rates and similar cumulative rates of acute rejection and allograft dysfunction, as assessed by means of serum creatinine levels.CONCLUSIONS: Our results suggest that transplantation of FS or FF kidneys to SS recipients is not advantageous, possibly because chronic allograft nephropathy is a multifaceted disease involving the interplay of many biologic pathways.

References Powered by Scopus

Complement C3 variant and the risk of age-related macular degeneration

751Citations
N/AReaders
Get full text

Local synthesis of complement component C3 regulates acute renal transplant rejection

450Citations
N/AReaders
Get full text

High Voltage Agarose Gel Electrophoresis in the Study of C 3 Polymorphism

198Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Delayed graft function in the kidney transplant

628Citations
N/AReaders
Get full text

The role of the anaphylatoxins in health and disease

575Citations
N/AReaders
Get full text

Molecules great and small: The complement system

232Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Varagunam, M., Yaqoob, M. M., Döhler, B., & Opelz, G. (2009). C3 Polymorphisms and Allograft Outcome in Renal Transplantation. New England Journal of Medicine, 360(9), 874–880. https://doi.org/10.1056/nejmoa0801861

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 20

45%

Researcher 11

25%

Professor / Associate Prof. 10

23%

Lecturer / Post doc 3

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 34

67%

Agricultural and Biological Sciences 12

24%

Biochemistry, Genetics and Molecular Bi... 3

6%

Immunology and Microbiology 2

4%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free